☆ 4.5 Article

Exploration of potential targets and mechanisms of naringenin in the treatment of nonalcoholic fatty liver disease through network pharmacology

MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

UniProt: the Universal Protein Knowledgebase in 2023

Alex Bateman et al.

Summary: The UniProt Knowledgebase aims to provide comprehensive, high-quality, and freely accessible protein sequences annotated with functional information. The database has expanded its data processing pipeline and website to accommodate the increasing information content, with over 227 million sequences and plans to include a reference proteome for each taxonomic group. Detailed annotations are extracted from the literature to update or create reviewed entries, while unreviewed entries are supplemented with annotations from automated systems. The new website, https://www.uniprot.org/, offers enhanced user experience and easy access to data, including AlphaFold structures and improved protein subcellular localization visualizations.

NUCLEIC ACIDS RESEARCH (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Comparative Toxicogenomics Database (CTD): update 2023

Allan Peter Davis et al.

Summary: The Comparative Toxicogenomics Database (CTD) is a unique resource that harmonizes data on chemical exposures and their biological repercussions across species, providing information and potential molecular mechanisms for environmental health research.

NUCLEIC ACIDS RESEARCH (2023)

Add to Collection

Article Gastroenterology & Hepatology

Prevalence of High and Moderate Risk Nonalcoholic Fatty Liver Disease Among Adults in the United States, 1999-2016

Pegah Golabi et al.

Summary: NAFLD subjects with fibrosis stage >= 2 have a high risk of mortality. The prevalence of moderate- or high-risk NAFLD is increasing over the years and is associated with increased all-cause, liver-related, and cardiovascular mortality.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial

Fatemeh Naeini et al.

Summary: This double-blind, placebo-controlled, randomized clinical trial investigated the effects of naringenin supplementation on cardiovascular complications in NAFLD patients. The results showed that naringenin supplementation significantly reduced atherogenic index, non-HDL-C levels, and various cholesterol ratios. It also resulted in a reduction in BMI and visceral fat level. These findings suggest that naringenin may be a promising treatment strategy for cardiovascular complications among NAFLD patients.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents

Ying Zhou et al.

Summary: Drug discovery relies not only on knowledge of drugs and targets, but also on understanding comparative agents and targets. This study introduces a major update to the Therapeutic Target Database, providing valuable data on poor binders, non-binders, prodrug-drug pairs, co-targets, and drug-like properties, as well as additional features for advanced search and cross-links to target structures. The database is accessible without login requirement at: https://idrblab.org/ttd/.

NUCLEIC ACIDS RESEARCH (2022)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Saroglitazar, a PPAR-α/γ Agonist, for Treatment of Nonalcoholic Fatty Liver Disease: A Randomized Controlled Double-Blind Phase 2 Trial

Manas Kumar Panigrahi et al.

JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2022)

Add to Collection

Review Endocrinology & Metabolism

Current insights in molecular characterization of non-alcoholic fatty liver disease and treatment

Wensheng Che et al.

Summary: The incidence of non-alcoholic fatty liver disease (NAFLD) is increasing worldwide, in parallel with the rise of metabolic diseases. NAFLD is closely related to metabolic syndrome and type 2 diabetes mellitus. Gut microbiota and functional molecules play important roles in the development and treatment of NAFLD.

FRONTIERS IN ENDOCRINOLOGY (2022)

Add to Collection

Review Nutrition & Dietetics

A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease

Fatemeh Naeini et al.

Summary: Naringenin, a natural flavanone, has shown promising therapeutic effects in the treatment of NAFLD by modulating various biological processes related to the disease. Its potency and efficacy compared to other antioxidants suggest that naringenin may be a potential therapeutic approach for managing NAFLD and associated complications. However, further robust clinical trials and human pharmacokinetic studies are needed to establish optimal dosage ranges and address safety concerns before larger-scale trials can be conducted.

ADVANCES IN NUTRITION (2021)

Add to Collection

Article Biochemistry & Molecular Biology

The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets

Damian Szklarczyk et al.

Summary: The STRING database integrates various associations between proteins, including physical interactions and functional associations, by collecting evidence from sources such as literature, databases, computational predictions, and systematic transfers. STRING aims for wide coverage and provides extensive user interface features and querying methods for experimental data.

NUCLEIC ACIDS RESEARCH (2021)

Add to Collection

Article Plant Sciences

Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe-/- mice: role of SIRT1

Yi Qiao Hua et al.

Summary: The administration of naringenin improved metabolic parameters, suppressed hepatic steatosis, regulated liver inflammation, and reduced oxidative stress levels, suggesting its potential as a therapeutic option for NASH treatment.

PHYTOMEDICINE (2021)

Add to Collection

Review Pharmacology & Pharmacy

Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease

Honglin Zhou et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is gradually becoming one of the most common chronic liver diseases in the world due to the improvement of living standards and changes in eating habits. Traditional Chinese medicines (TCM) have attracted attention for their multi-target and multi-channel mechanisms in treating NAFLD, showing potential through regulating various pathways for ameliorating the disease.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Add to Collection

Article Genetics & Heredity

Protein Function Prediction Based on PPI Networks: Network Reconstruction vs Edge Enrichment

Jiaogen Zhou et al.

Summary: The study found that edge enrichment in PPI networks works better than network reconstruction and original networks, with sequence similarity outperforming both local and global similarity. These results are helpful for biologists to choose suitable pre-processing schemes and achieve more accurate protein function prediction.

FRONTIERS IN GENETICS (2021)

Add to Collection

Review Medicine, General & Internal

Non-alcoholic fatty liver disease

Elizabeth E. Powell et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is a common global health issue with significant associations with metabolic syndrome and type 2 diabetes, leading to serious complications like cirrhosis and hepatocellular carcinoma. While cardiovascular disease and extrahepatic malignancy are the main causes of death in NAFLD patients, advanced liver fibrosis is a key prognostic marker for liver-related outcomes and overall mortality.

LANCET (2021)

Add to Collection

Article Gastroenterology & Hepatology

Maternal nicotine exposure aggravates metabolic associated fatty liver disease via PI3K/Akt signaling in adult offspring mice

Shu-Jing Huang et al.

Summary: The study demonstrated that maternal nicotine exposure can significantly decrease the weight and inhibit organ growth in offspring mice, increase serum lipid levels, induce insulin resistance, and affect lipid metabolism through the activation of specific signaling pathways.

LIVER INTERNATIONAL (2021)

Add to Collection

Review Genetics & Heredity

A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations

Guillaume Canaud et al.

Summary: PIK3CA-related disorders encompass a range of conditions involving overgrowth and vascular malformations caused by mutations in the PIK3CA gene. Diagnosis can be challenging due to overlapping phenotypes, and treatment response is typically assessed through clinical improvement, radiological response, and patient-reported outcomes. Current therapeutic options include the mTOR inhibitor sirolimus, but other agents targeting the PI3K pathway are under investigation. Management of these disorders requires a multidisciplinary approach, and ongoing clinical studies will provide further insights into treatment options.

ORPHANET JOURNAL OF RARE DISEASES (2021)

Add to Collection

Article Gastroenterology & Hepatology

Saroglitazar, a PPAR-α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double-Blind Phase 2 Trial

Samer Gawrieh et al.

Summary: Saroglitazar showed significant efficacy in patients with NAFLD/NASH, improving ALT, liver fat content and insulin resistance. The 4mg dose of Saroglitazar also demonstrated significant improvements in lipid metabolism and lipoprotein particle composition. Overall, Saroglitazar was well-tolerated with a slight weight gain observed in patients.

HEPATOLOGY (2021)

Add to Collection

Article Pharmacology & Pharmacy

Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3/NF-κB pathway in mice

Qinyu Wang et al.

BRITISH JOURNAL OF PHARMACOLOGY (2020)

Add to Collection

Review Gastroenterology & Hepatology

The gut-liver axis in liver disease: Pathophysiological basis for therapy

Agustin Albillos et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Review Pharmacology & Pharmacy

Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH)

Stefano Fiorucci et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)

Add to Collection

Article Multidisciplinary Sciences

The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease

Divya P. Kumar et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Cell Biology

Aucubin inhibited lipid accumulation and oxidative stress via Nrf2/HO-1 and AMPK signalling pathways

Bingyu Shen et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

Add to Collection

Article Multidisciplinary Sciences

Metascape provides a biologist-oriented resource for the analysis of systems-level datasets

Yingyao Zhou et al.

NATURE COMMUNICATIONS (2019)

Add to Collection

Review Gastroenterology & Hepatology

Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease

Reenam S. Khan et al.

HEPATOLOGY (2019)

Add to Collection

Article Biochemistry & Molecular Biology

ETCM: an encyclopaedia of traditional Chinese medicine

Hai-Yu Xu et al.

NUCLEIC ACIDS RESEARCH (2019)

Add to Collection

Article Biochemistry & Molecular Biology

DrugBank 5.0: a major update to the DrugBank database for 2018

David S. Wishart et al.

NUCLEIC ACIDS RESEARCH (2018)

Add to Collection

Article Gastroenterology & Hepatology

Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030

Chris Estes et al.

JOURNAL OF HEPATOLOGY (2018)

Add to Collection

Article Biochemistry & Molecular Biology

FXR activation by obeticholic acid or nonsteroidal agonists induces a human-like lipoprotein cholesterol change in mice with humanized chimeric liver

Romeo Papazyan et al.

JOURNAL OF LIPID RESEARCH (2018)

Add to Collection

Review Gastroenterology & Hepatology

Beneficial effects of naringenin in liver diseases: Molecular mechanisms

Erika Hernandez-Aquino et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2018)

Add to Collection

Review Gastroenterology & Hepatology

Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis

Bei Li et al.

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)

Add to Collection

Review Endocrinology & Metabolism

The role of hypoxia-inducible factors in metabolic diseases

Frank J. Gonzalez et al.

NATURE REVIEWS ENDOCRINOLOGY (2018)

Add to Collection

Article Oncology

Inhibition of JNK suppresses autophagy and attenuates insulin resistance in a rat model of nonalcoholic fatty liver disease

Hua Yan et al.

MOLECULAR MEDICINE REPORTS (2017)

Add to Collection

Article Biochemistry & Molecular Biology

DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants

Janet Pinero et al.

NUCLEIC ACIDS RESEARCH (2017)

Add to Collection

Editorial Material Cell Biology

MAPK1/3 regulate hepatic lipid metabolism via ATG7-dependent autophagy

Yuzhong Xiao et al.

AUTOPHAGY (2016)

Add to Collection

Article Endocrinology & Metabolism

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)

Elena Buzzetti et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2016)

Add to Collection

Article Medicine, General & Internal

A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

F. Nevens et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Add to Collection

Article Oncology

HIF-1 suppresses lipid catabolism to promote cancer progression

Huafeng Zhang

MOLECULAR & CELLULAR ONCOLOGY (2015)

Add to Collection

Article Pharmacology & Pharmacy

Naringenin attenuates CCl4-induced hepatic inflammation by the activation of an Nrf2-mediated pathway in rats

Mohammad Ali Esmaeili et al.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2014)

Add to Collection

Article Biochemistry & Molecular Biology

SwissTargetPrediction: a web server for target prediction of bioactive small molecules

David Gfeller et al.

NUCLEIC ACIDS RESEARCH (2014)

Add to Collection

Article Chemistry, Multidisciplinary

TCMSP: a database of systems pharmacology for drug discovery from herbal medicines

Jinlong Ru et al.

JOURNAL OF CHEMINFORMATICS (2014)

Add to Collection

Article Biochemistry & Molecular Biology

PubChem's BioAssay Database

Yanli Wang et al.

NUCLEIC ACIDS RESEARCH (2012)

Add to Collection

Article Endocrinology & Metabolism

Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation

R. R. Ortiz-Andrade et al.

DIABETES OBESITY & METABOLISM (2008)

Add to Collection

Article Biochemistry & Molecular Biology

Inhibition of apoB secretion from HepG2 cells by insulin is amplified by naringenin, independent of the insulin receptor

Emma M. Allister et al.

JOURNAL OF LIPID RESEARCH (2008)

Add to Collection

Article Biochemistry & Molecular Biology

Cytoscape: A software environment for integrated models of biomolecular interaction networks

P Shannon et al.

GENOME RESEARCH (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.